Beam Therapeutics Inc. logo BEAM - Beam Therapeutics Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 8
SELL 1
STRONG
SELL
0
| PRICE TARGET: $48.00 DETAILS
HIGH: $80.00
LOW: $26.00
MEDIAN: $40.00
CONSENSUS: $48.00
UPSIDE: 67.60%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue 139.7 63.5 377.7 60.9 51.8 0.0 0.0 0 0
Cost of Revenue 22.3 367.6 0 311.6 232.1 103.2 54.6 33.9 0
Gross Profit 117.4 (304.0) 377.7 (250.7) (180.3) (103.2) (54.6) (33.9) 0
Operating Expenses
R&D Expenses 409.6 367.6 437.4 311.6 387.1 103.2 54.6 33.9 5.9
SG&A Expenses 113.8 111.5 116.8 87.8 57.2 29.6 20.6 11.9 2.2
Other Expenses (22.3) (367.6) 0 (311.6) (232.1) (103.2) (54.6) (33.9) 0
Operating Expenses 501.1 111.5 554.2 87.8 212.2 29.6 20.6 11.9 8.6
Operating Income
Operating Income (383.7) (415.6) (176.5) (338.5) (392.5) (132.8) (75.2) (45.7) (8.6)
Interest Expense 43.7 0 0 0 0 0 0.2 0 0
Interest Income 0 49.1 0 0 0 1.6 2.5 0.3 0
Profitability
EBITDA (29.9) (393.6) (147.0) (324.3) (230.1) (128.0) (71.7) (45.1) (8.6)
EBIT (36.3) (415.6) (176.5) (338.5) (237.5) (132.8) (75.2) (45.7) (8.6)
Income Before Tax (80.0) (376.7) (131.2) (285.7) (370.6) (194.6) (78.3) (116.7) (8.7)
Income Tax Expense 0 0.0 1.4 3.4 0 0 0 0 0.5
Net Income (80.0) (376.7) (132.5) (289.1) (370.6) (194.6) (78.3) (115.3) (8.7)
Per Share Data
EPS (Basic) -0.81 -4.58 -1.72 -4.13 -5.77 -5.49 -1.53 -3.28 -0.62
EPS (Diluted) -0.81 -4.58 -1.72 -4.13 -5.77 -5.49 -1.53 -3.28 -0.62
Shares Outstanding 98.9 82.3 77.2 70.0 64.2 46.7 51.3 35.1 13.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Current Assets
Cash & Cash Equivalents 294.9 282.0 435.9 232.8 560.0 162.2 37.2 146.4 1.9
Short-Term Investments 950.3 568.8 754.0 845.4 405.7 137.5 54.6 0 0
Net Receivables 0 0 0 0 300 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 0 27.4 21.2 14.8 0 0 0 0 0
Total Current Assets 1,268.7 878.1 1,211.0 1,092.9 1,273.0 308.3 94.5 148.3 2.0
Non-Current Assets
Property, Plant & Equipment 205.2 216.3 237.8 234.1 187.0 125.4 43.2 16.9 0.3
Goodwill 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Long-Term Investments 6.7 0 0 0 0 0 0 1.5 0.0
Other Non-Current Assets 0.6 9.4 10.9 14.7 14.5 18.0 18.3 0.3 0
Total Non-Current Assets 212.5 225.7 248.7 248.8 201.4 143.4 61.6 18.7 0.4
Total Assets 1,481.2 1,103.8 1,459.7 1,341.7 1,474.5 451.7 156.1 167.0 2.4
Current Liabilities
Account Payables 10.2 3.9 1.6 9.0 7.5 6.3 7.8 7.4 0.7
Short-Term Debt 14.4 0 0 0 2.3 2.1 1.3 0 1.0
Deferred Revenue 6.7 108.9 68.7 136.0 86.3 0.0 0 0 (1.0)
Other Current Liabilities 36.3 19.7 100.7 49.7 60.8 83.0 12.6 16.5 4.7
Total Current Liabilities 96.9 182.1 205.6 223.6 213.4 102.3 29.1 25.6 6.6
Non-Current Liabilities
Long-Term Debt 139.8 0 0 0 3.0 5.3 4.4 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities (133.6) 7.0 3.0 13.8 34.2 2.1 0.4 7.4 0.0
Total Non-Current Liabilities 145.9 188.2 272.8 384.6 434.3 103.8 26.0 7.4 0.0
Total Liabilities 242.8 370.3 478.4 608.2 647.7 206.1 55.2 33.0 6.6
Stockholders' Equity
Common Stock 1.0 0.8 0.8 0.7 0.7 0.6 0.1 0.1 0.0
Retained Earnings (1,641.2) (1,566.6) (1,189.9) (1,057.4) (768.3) (397.6) (203.0) (124.7) (9.5)
Accumulated Other Comprehensive Income 1.1 0.7 0.6 (2.4) (0.1) (0.0) 0.0 (0.7) (0.0)
Total Stockholders' Equity 1,238.4 733.5 981.3 733.5 826.7 245.6 100.9 134.0 (4.2)
Total Liabilities & Equity 1,481.2 1,103.8 1,459.7 1,341.7 1,474.5 451.7 156.1 167.0 2.4
Debt Metrics
Total Debt 293.9 161.4 172.7 179.0 147.6 107.6 31.2 0 1.0
Net Debt (1.1) (120.5) (263.2) (53.8) (412.4) (54.5) (6.0) (146.4) (0.9)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Operating Activities
Net Income (80.0) (376.7) (132.5) (289.1) (370.6) (194.6) (78.3) (116.7) (8.0)
Depreciation & Amortization 22.3 21.9 20.0 14.1 7.5 4.7 3.5 0.7 0.0
Stock-Based Compensation 94.2 120.7 98.6 84.3 43.6 15.4 7.0 7.0 0.2
Change in Working Capital (131.0) (110.2) (116.5) 251.6 111.3 5.3 (10.7) 10.1 0.7
Other Non-Cash Items (250.6) (2.9) (18.9) (38.5) 142.1 9.9 6.5 67.0 3.8
Operating Cash Flow (345.1) (347.2) (149.2) 22.5 (66.3) (95.7) (72.0) (20.3) (2.7)
Investing Activities
Capital Expenditure (14.9) (8.9) (33.7) (49.0) (46.8) (16.4) (12.5) (13.1) (0.3)
Acquisitions (0.1) 0 0 412.4 0.6 83.8 0 0 0
Purchases of Investments (1,209.8) (486.4) (984.3) (1,617.0) (777.2) (282.4) (130.2) (0.3) 0
Sales/Maturities of Investments 848.6 680.4 1,089.9 1,204.6 529.3 198.6 76.1 0 0
Other Investing Activities 254.7 0 0 (412.4) 0 (83.8) 0 (0.3) 0
Investing Cash Flow (121.4) 185.0 71.8 (461.3) (294.1) (100.1) (66.7) (13.4) (0.3)
Financing Activities
Net Debt Issuance 0 (0.5) (2.3) (2.3) (2.1) 1.7 5.7 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 8.5 5.6 0.8 1.1 (2.3) 0.0 0
Financing Cash Flow 478.0 7.7 276.4 111.6 756.1 322.3 41.3 179.7 5.0
Cash Position
Net Change in Cash 11.5 (154.5) 199.1 (327.2) 395.7 126.5 (97.4) 146.0 1.9
Cash at Beginning 290.1 444.6 245.5 572.7 177.0 50.6 147.9 1.9 0
Cash at End 301.6 290.1 444.6 245.5 572.7 177.0 50.6 147.9 1.9
Free Cash Flow (360.0) (356.2) (182.9) (26.4) (113.1) (112.1) (84.5) (33.4) (3.1)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017
Income Statement
Revenue 139.7 63.5 377.7 60.9 51.8 0.0 0.0 0 0
Gross Profit 117.4 (304.0) 377.7 (250.7) (180.3) (103.2) (54.6) (33.9) 0
Operating Income (383.7) (415.6) (176.5) (338.5) (392.5) (132.8) (75.2) (45.7) (8.6)
Net Income (80.0) (376.7) (132.5) (289.1) (370.6) (194.6) (78.3) (115.3) (8.7)
EPS (Diluted) -0.81 -4.58 -1.72 -4.13 -5.77 -5.49 -1.53 -3.28 -0.62
Balance Sheet
Cash & Equivalents 294.9 282.0 435.9 232.8 560.0 162.2 37.2 146.4 1.9
Total Assets 1,481.2 1,103.8 1,459.7 1,341.7 1,474.5 451.7 156.1 167.0 2.4
Total Debt 293.9 161.4 172.7 179.0 147.6 107.6 31.2 0 1.0
Stockholders' Equity 1,238.4 733.5 981.3 733.5 826.7 245.6 100.9 134.0 (4.2)
Cash Flow
Operating Cash Flow (345.1) (347.2) (149.2) 22.5 (66.3) (95.7) (72.0) (20.3) (2.7)
Capital Expenditure (14.9) (8.9) (33.7) (49.0) (46.8) (16.4) (12.5) (13.1) (0.3)
Free Cash Flow (360.0) (356.2) (182.9) (26.4) (113.1) (112.1) (84.5) (33.4) (3.1)